Tyra Biosciences, Inc. Variable Lease, Cost
Tyra Biosciences, Inc. (TYRA) reported Variable Lease, Cost of $39.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- Tyra Biosciences, Inc. variable lease, cost for the quarter ending 2026-06-30 was $39.00K, a 11.43% increase year-over-year.
- Tyra Biosciences, Inc. variable lease, cost for the quarter ending 2026-03-31 was $40.00K, a 21.21% increase year-over-year.
- Tyra Biosciences, Inc. variable lease, cost for the quarter ending 2025-12-31 was $36.00K, a 12.50% increase year-over-year.
- Tyra Biosciences, Inc. variable lease, cost for the quarter ending 2025-09-30 was $35.00K, a 9.38% increase year-over-year.
- Tyra Biosciences, Inc. variable lease, cost for fiscal 2025 was $139.00K, a 9.45% increase from fiscal 2024.
- Tyra Biosciences, Inc. variable lease, cost for fiscal 2024 was $127.00K, a 60.76% increase from fiscal 2023.
- Tyra Biosciences, Inc. variable lease, cost for fiscal 2023 was $79.00K, a 41.07% increase from fiscal 2022.
- Tyra Biosciences, Inc. variable lease, cost for fiscal 2022 was $56.00K, a 250.00% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-04 | $79.00K 10-Q · filed 2026-08-04 | $115.00K derived: sum of 3 quarters · filed 2026-08-04 | $150.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $40.00K 10-Q · filed 2026-05-13 | $76.00K derived: sum of 2 quarters · filed 2026-05-13 | $111.00K derived: sum of 3 quarters · filed 2026-05-13 | $146.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $71.00K derived: sum of 2 quarters · filed 2026-03-02 | $106.00K derived: sum of 3 quarters · filed 2026-08-04 | $139.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-05 | $70.00K derived: sum of 2 quarters · filed 2026-08-04 | $103.00K 10-Q · filed 2025-11-05 | $135.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $35.00K 10-Q · filed 2026-08-04 | $67.00K 10-Q · filed 2026-08-04 | $100.00K derived: sum of 3 quarters · filed 2026-08-04 | $132.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $33.00K 10-Q · filed 2026-05-13 | $65.00K derived: sum of 2 quarters · filed 2026-05-13 | $97.00K derived: sum of 3 quarters · filed 2026-05-13 | $129.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $64.00K derived: sum of 2 quarters · filed 2026-03-02 | $96.00K derived: sum of 3 quarters · filed 2026-03-02 | $127.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $32.00K 10-Q · filed 2025-11-05 | $64.00K derived: sum of 2 quarters · filed 2025-11-05 | $95.00K 10-Q · filed 2025-11-05 | $122.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $32.00K 10-Q · filed 2025-08-14 | $63.00K 10-Q · filed 2025-08-14 | $90.00K derived: sum of 3 quarters · filed 2025-08-14 | $109.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-08 | $58.00K derived: sum of 2 quarters · filed 2025-05-08 | $77.00K derived: sum of 3 quarters · filed 2025-05-08 | $92.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $45.00K derived: sum of 2 quarters · filed 2025-03-27 | $60.00K derived: sum of 3 quarters · filed 2025-03-27 | $79.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $19.00K 10-Q · filed 2024-11-07 | $34.00K derived: sum of 2 quarters · filed 2024-11-07 | $53.00K 10-Q · filed 2024-11-07 | $58.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $15.00K 10-Q · filed 2024-08-07 | $29.00K 10-Q · filed 2024-08-07 | $39.00K derived: sum of 3 quarters · filed 2024-08-07 | $55.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-09 | $24.00K derived: sum of 2 quarters · filed 2024-05-09 | $40.00K derived: sum of 3 quarters · filed 2024-05-09 | $54.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $26.00K derived: sum of 2 quarters · filed 2024-03-19 | $40.00K derived: sum of 3 quarters · filed 2024-03-19 | $56.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-07 | $30.00K derived: sum of 2 quarters · filed 2023-11-07 | $46.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $14.00K 10-Q · filed 2023-08-10 | $30.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $16.00K 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |